. Antignac, Les réformes de la réglementation en Inde et leur effet favorable sur la pénétration et les tarifs du mobile, Pour atteindre une sensibilité de l'ordre de 0,01µM, nous avons poursuivi notre étude par l'évaluation du couplage de la chromatographie liquide à la spectrométrie de masse

, Graphique 6.6 Peur de la défaillance et taux de recouvrement dans le cadre de procédures d?insolvabilité, A la concentration supérieure de 1000ng/mL, trois composés (C, D et I) présentaient un taux de recouvrement conforme à nos critères (95,0 à 105,0%)

, 9.7. Le revenu disponible des personnes âgées se compose principalement de la pension et de revenus du capital

. Toutefois, Les organisations de la société civile rapportent que des consultations ne sont pas systématiquement utilisées pour orienter les politiques nationales de développement, 2019.

. Annesley-t, Ion Suppression in Mass Spectrometry, Clinical Chemistry, vol.49, issue.7, pp.1041-1044, 2003.

A. De-wasch-k, F. Monteau, . De-brabander-h, . Andre-f, and . Le-bizec-b, The ion suppression phenomenon in liquid chromatography-mass spectrometry and its consequences in the field of residue analysis, Anal Chim Acta, vol.529, pp.129-136, 2005.

. Arpino-p, Couplages chromatographiques avec la spectrométrie de masse. I, 2007.

. Arpino-p, Couplages chromatographiques avec la spectrométrie de masse, 2009.

. Borchardt-r, . Kerns-e, C. Lipinski, D. Thakker, and . Wang-b, Optimizing the ?Drug-Like? Properties of Leads in Drug Discovery, p.482, 2006.

. Bouchoux-g and . Sablier-m, Ionisation et Fragmentation en Spectrométrie de Masse. VII?Structure de l'Ion [C6H6O]+ Issu de la Décomposition du Phényléthyléther Sous Impact Electronique, Organic Mass Spectrometry, vol.13, issue.4, pp.184-187, 1978.

J. C. Brimecombe, G. E. Kirsch, and A. M. Brown, Test article concentrations in the hERG assay: Losses through the perfusion, solubility and stability, Journal of Pharmacological and Toxicological Methods, vol.59, issue.1, pp.29-34, 2009.

. Carr-g, Using Tandem LC-MS for Cleaning Validation, Pharma Tech Europe, vol.25, issue.8, pp.28-29, 2013.

M. Caude, Chromatographie en phase liquide -Théorie et méthodes de séparation, 1994.

. Chorghade-m, Drug Discovery and Development, vol.2, p.400, 2007.

E. De-hoffmann and . Stroobant-v, Mass Spectrometry: Principles and Applications. 3ème édition, p.489, 2007.

A. D. De-jager and N. L. Bailey, Online extraction LC?MS/MS method for the simultaneous quantitative confirmation of urine drugs of abuse and metabolites: Amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone, Journal of Chromatography B, vol.879, issue.25, pp.2642-2652, 2011.

D. L. Fish-p and . Mano-t, Bridging solubility between drug discovery and development, Drug Discov Today, vol.17, issue.9, pp.486-495, 2012.

G. Smith, European Medicines Agency guideline on bioanalytical method validation: what more is there to say?, Bioanalysis, vol.4, issue.8, pp.865-868, 2012.

. Fanali-s, . Haddad-p, C. Poole, P. Schoenmakers, and . Lloyd-d, Liquid Chromatography: Applications, p.688, 2013.

R. R. Brodie and H. M. Hill, Validation issues arising from the new FDA guidance for industry on bioanalytical method validation, Chromatographia, vol.55, issue.S1, pp.S91-S94, 2002.

C. Fernández-ramos, D. ?atínský, and P. Solich, New method for the determination of carbamate and pyrethroid insecticides in water samples using on-line SPE fused core column chromatography, Talanta, vol.129, pp.579-585, 2014.

F. A. Attwood-d, Physicochemical Principles of Pharmacy. 5 ème édition, p.510, 2011.

S. Goineau, J. Lacaud, C. Legrand, E. Eveilleaux, and G. Froget, Unsuitability of hydroxypropyl-beta-cyclodextrin for use in the hERG channel test, Journal of Pharmacological and Toxicological Methods, vol.70, issue.3, p.316, 2014.

F. Gritti and G. Guiochon, Comparison of heat friction effects in narrow-bore columns packed with core?shell and totally porous particles, Chemical Engineering Science, vol.65, issue.23, pp.6310-6319, 2010.

H. Guenard, Physiologie humaine. 3 ème édition. Pradel Ed, p.606, 2001.

. Guillarme-d, 1er symposium international de chromatographie en phase liquide préparative et de chromatographie de production, Biochimie, vol.67, issue.12, pp.XVII-XVIII, 1985.

J. C. Hancox, M. J. Mcpate, A. El-harchi, and Y. H. Zhang, The hERG potassium channel and hERG screening for drug-induced torsades de pointes, Pharmacology & Therapeutics, vol.119, issue.2, pp.118-132, 2008.

, Sommaire des Recommandations de bonne pratique de la Haute Autorité de Santé (HAS), Maladie d'Alzheimer et troubles de la communication, p.143, 2011.

W. Herron, C. Towers, and A. Templeton, Experiences in method development for the analysis of in vitro study solutions for content, Journal of Pharmacological and Toxicological Methods, vol.49, issue.3, pp.211-216, 2004.

H. Himmel, Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential, Journal of Pharmacological and Toxicological Methods, vol.56, issue.2, pp.145-158, 2007.

P. Hoffmann and B. Warner, Are hERG channel inhibition and QT interval prolongation all there is in drug-induced torsadogenesis? A review of emerging trends, Journal of Pharmacological and Toxicological Methods, vol.53, issue.2, pp.87-105, 2006.

M. Stonerook, Overview of Respiratory Studies to Support ICH S7A, Principles of Safety Pharmacology, pp.131-148, 2015.

I. Directive, The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals, 2005.

M. Josefsson and A. Sabanovic, Sample preparation on polymeric solid phase extraction sorbents for liquid chromatographic-tandem mass spectrometric analysis of human whole blood?A study on a number of beta-agonists and beta-antagonists, Journal of Chromatography A, vol.1120, issue.1-2, pp.1-12, 2006.

Y. Landry, J. Gies, and . Pharmacologie, Correction de l?anémie des insuffisants rénaux chroniques : quelles cibles ?, Néphrologie & Thérapeutique, vol.4, pp.1-8, 2008.

. Law-b and . Temesi-d, Factors to consider in the development of generic bioanalytical highperformance liquid chromatographic-mass spectrometric methods to support drug discovery, J Chromatogr B, vol.748, pp.21-30, 2000.

. Lee-m, . Y. Oh-s, . S. Pathak-t, . R. Paeng-i, and P. Cho-b.-y, Selective solidphase extraction of catecholamines by the chemically modified polymeric adsorbents with crown ether, J Chromatogr A, pp.340-344, 1160.

L. W. Zhang, J. Tse-f, . Handbook, . Lc-ms, and . Bioanalysis, Handbook of LC-MS Bioanalysis, Best Practices, Experimental Protocols, and Regulations, p.704, 2013.

C. Lipinski, Lead- and drug-like compounds: the rule-of-five revolution, Drug Discovery Today: Technologies, vol.1, issue.4, pp.337-341, 2004.

. Loftsson-t, Stability Testing, Drug Stability for Pharmaceutical Scientists, pp.121-125, 2014.

. Mahato-r and . Narang-a, Pharmaceutical Dosage Forms and Drug Delivery, SECOND EDITION, p.512, 2011.

M. B. Électrospray, Application of Electrospray Ionization Mass Spectrometry to Unusual Phosphorylated Oligosaccharides of Trypanosoma cruzi, Techniques in Glycobiology, pp.91-100, 1997.

, Principes de bonnes pratiques de laboratoire et vérification du respect de ces principes, vol.2, p.24, 1999.

Y. Özkan, N. Y?lmaz, S. A. Özkan, and ?. Biryol, High-performance liquid chromatographic analysis of verapamil and its application to determination in tablet dosage forms and to drug dissolution studies, Il Farmaco, vol.55, issue.5, pp.376-382, 2000.

. Pharmacopee-europeenne, , vol.8, 2015.

. Pichon-v, Extraction sur phase solide pour l'analyse de composés organiques, 2006.

Y. Qu, P. Schnier, R. Zanon, and H. M. Vargas, hERG potency estimates based upon dose solution analysis: What have we learned?, Journal of Pharmacological and Toxicological Methods, vol.64, issue.3, pp.251-257, 2011.

D. Rampe and A. M. Brown, A history of the role of the hERG channel in cardiac risk assessment, Journal of Pharmacological and Toxicological Methods, vol.68, issue.1, pp.13-22, 2013.

G. Rast and B. D. Guth, Solubility assessment and on-line exposure confirmation in a patch-clamp assay for hERG (human ether-a-go-go-related gene) potassium channel inhibition, Journal of Pharmacological and Toxicological Methods, vol.70, issue.2, pp.182-187, 2014.

W. Redfern, L. Carlsson, A. Davis, W. Lynch, I. Mackenzie et al., Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development, Cardiovascular Research, vol.58, issue.1, pp.32-45, 2003.

R. D. Dejean-c, Mechanisms of Acquired QT Prolongation and Torsades de Pointes, Acquired Long QT Syndrome, vol.266, pp.8-23

A. Rouessac, F. Rouessac, and H. Zamarlik, Phenylselenolactonisation des acides homogeranique et homonerique, Tetrahedron Letters, vol.22, issue.28, pp.2641-2642, 1981.

. Rouquerol-f, G. Chambaud, . Lissillour-r, and . Boucekkine-a.-chimie-générale,

A. C. Sanchez, J. A. Anspach, and T. Farkas, Performance optimizing injection sequence for minimizing injection band broadening contributions in high efficiency liquid chromatographic separations, Journal of Chromatography A, vol.1228, pp.338-348, 2012.

L. R. Snyder, J. J. Kirkland, and J. L. Glajch, Practical HPLC Method Development, p.800, 1997.

. Swartz-m, Seeing is Believing: Detectors for HPLC, LCGC North America, issue.10, p.28, 2010.

;. Disponible, J. Vandenberg, . Walker-b, and . Campbell-t, HERG K + channels: friend and foe, Trends Pharmacol Sci, vol.22, issue.5, pp.240-246, 2001.

W. M. , Integrated risk assessment and predictive value to humans of non-clinical repolarization assays, Br J Pharmacol, vol.159, pp.115-121, 2010.

W. T. Andrews-r, Recent innovations in UHPLC columns and instrumentation, Trends Analyt Chem, vol.63, pp.14-20, 2014.

. Yao-j-a, X. Du, . Lu-d, . Baker-r, E. Daharsh et al., Estimation of potency of HERG channel blockers: Impact of voltage protocol and temperature, J Pharmacol Toxicol Methods, vol.52, pp.146-153, 2005.

. Yoshioka-s and . Stella-v, Stability of Dosage Forms, Stability of Drugs and Dosage Forms, vol.268, pp.151-186

L. Zhao and F. Li, UHPLC-MS strategies and applications for bioanalyses related to pharmacokinetics and drug metabolism, TrAC Trends in Analytical Chemistry, vol.63, pp.170-179, 2014.

, The new Agilent 1290 Infinity II LC, Chemical & Engineering News Archive, vol.92, issue.40, p.15, 2014.

B. Varet, Le point de vue des professionnels de santé quant à l?information à donner sur les produits de santé : le point de vue du médecin, Information et produits de santé, quelles perspectives ?, p.95, 2006.

. Lateef-s, . Dong-m, and . Gu-c, TPM Fundamentals, Practical TPM, pp.3-12, 2001.

, Finlande, Statistiques de l'OCDE sur les dépenses en recherche et développement dans l'industrie, pp.26-29, 2014.

E. Perkin, Charges administratives sur la création d'entreprises, Présentation du détecteur Flexar PDA Plus, disponible sur, 2014.

L. Humbert, Extraction en phase solide (SPE) : théorie et applications, Annales de Toxicologie Analytique, vol.22, issue.2, pp.61-68, 2010.

». Shimadzu.-liste-des-détecteurs-uv-vis-et-«-photodiode-array, HPLC detector from Shimadzu, Marine Pollution Bulletin, vol.28, issue.1, p.58, 1994.

?. Sigma-aldrich-;--spectroscopy and . 8%-», Rapport du nombre d'infirmiers sur le nombre de médecins, Spécifications du produit « Dimethyl sulfoxide for UV, 2014.

S. Waters.-gamme-de-produits-d'extraction-oasis®, Gerbillus watersi Waters?s Gerbil : Fr. Gerbille de Waters; Ger. Waters Rennmaus, Mammals of Africa : Rodents, Hares and Rabbits

C. Laveissière and C. Penchenier, Annexe 13. Cahier du poste CATT, Manuel de lutte contre la maladie du sommeil, p.298